Biohaven
BHVN · NYSE
Bulios Fair Price
$8.45
37.9% downside
Preț actual
$13.61
Potrivit Bulios Fair Price, acțiunile BHVN sunt în prezent supraevaluate față de prețul lor de piață. Cum funcționează?
Bulios Fair Price este o estimare a valorii corecte a unei acțiuni din modelul de evaluare Bulios. Este un punct de plecare pentru propria analiză, nu o recomandare de investiții. Cum funcționează?
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Despre companie
Biohaven Pharmaceutical Holding Company Ltd. (BHVN) is a biotechnology company focused on researching, developing, and commercializing therapeutic products for the treatment of neurological and psychiatric disorders. The company aims to discover novel drug candidates and innovative therapies for patients suffering from migraine, Alzheimer's disease, amyotrophic lateral sclerosis (ALS), and other neurological disorders. Biohaven is advancing and testing drugs in various stages of clinical trials and aspires to bring new therapeutic solutions to the field of neurological treatment. The company collaborates with academic and industry partners and focuses on innovation in the field of neuroscience. Biohaven Pharmaceutical Holding Company Ltd. (BHVN) shares may present an attractive investment opportunity for investors monitoring the biotechnology sector and seeking investments in a company with promising neurological treatment innovations and a strong commitment to addressing neurological disorders.
Nu este încă disponibil în limba dumneavoastră, așa că textul este în engleză.
Sector
Healthcare
Industry
Biotechnology
CEO
Vladimir Coric
Employees
274
Headquarters
New Haven
Evenimente viitoare
Earnings
Upcoming earnings report